journal
https://read.qxmd.com/read/39183082/translation-and-validation-of-the-thai-version-of-the-japanese-sleep-questionnaire-for-preschoolers-jsq-p
#1
JOURNAL ARTICLE
Natcha Lueangapapong, Jariya Chuthapisith, Lunliya Thampratankul
PURPOSE: This study aimed to translate and validate the Japanese Sleep Questionnaire for Preschoolers (JSQ-P) into a Thai version and to evaluate factors associated with sleep problems in preschoolers. METHODS: The cross-cultural adaptation of JSQ-P into Thai version of JSQ-P (TH-JSQ-P) was performed including forward translation, reconciliation, backward translation, and final approval by the original creator. Children aged 2-6 years from community and clinical settings were enrolled...
August 24, 2024: Brain & Development
https://read.qxmd.com/read/39164139/a-nationwide-survey-of-vici-syndrome-in-japan
#2
JOURNAL ARTICLE
Ikumi Hori, Toshihiko Iwaki, Emi Sato, Daisuke Ieda, Yutaka Negishi, Ayako Hattori, Shinji Saitoh
BACKGROUND: Vici syndrome (VICIS) is a congenital disorder characterized by agenesis of the corpus callosum, cataracts, hypopigmentation, cardiomyopathy, combined immunodeficiency, microcephaly, and failure to thrive. This study aimed to elucidate the number of patients with VICIS, its clinical characteristics and relevant genetic information in Japan. METHODS: After developing diagnostic criteria for VICIS, we conducted a nationwide questionnaire-based survey of VICIS in Japan...
August 19, 2024: Brain & Development
https://read.qxmd.com/read/39142946/long-term-observation-of-patients-with-advanced-late-onset-pompe-disease-undergoing-enzyme-replacement-therapy-a-15-year-observation-in-a-single-center
#3
JOURNAL ARTICLE
Madoka Mori-Yoshimura, Hotake Takizawa, Atsushi Unuma, Yasushi Oya, Keisuke Yorimoto, Wakana Katsuta, Kenji Miyagi, Noriko Sato, Takatoshi Hara, Yuji Takahashi
BACKGROUND: There have been few descriptions in the literature on long-term enzyme replacement therapy (ERT) in patients with advanced late-onset Pompe disease (LOPD). OBJECTIVES: This study aimed to assess the efficacy and limitations of ERT in advanced LOPD patients. METHODS: We retrospectively reviewed the clinical courses of patients with advanced LOPD (two juvenile-onset and five adult-onset patients) who were treated with recombinant human alglucosidase alfa to examine improvements achieved with and limitations of ERT until their death or when switching to avalglucosidase alfa occurred...
August 13, 2024: Brain & Development
https://read.qxmd.com/read/39089917/epileptic-foci-and-networks-in-children-with-epilepsy-after-acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion
#4
JOURNAL ARTICLE
Takamasa Mitsumatsu, Yuji Ito, Yuki Maki, Hiroyuki Yamamoto, Fumi Sawamura, Tomotaka Ishizaki, Satoshi Maesawa, Epifanio Bagarinao, Tomohiko Nakata, Hiroyuki Kidokoro, Ryuta Saito, Jun Natsume
BACKGROUND: Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) develops along with status epilepticus and widespread subcortical white matter edema. We aimed to evaluate the epileptic foci and networks in two patients with epilepsy after AESD using simultaneous electroencephalography and functional magnetic resonance imaging (EEG-fMRI). METHODS: Statistically significant blood oxygen level-dependent (BOLD) responses related to interictal epileptiform discharges (IEDs) were analyzed using an event-related design of hemodynamic response functions with multiple peaks...
July 31, 2024: Brain & Development
https://read.qxmd.com/read/39069445/clinical-biochemical-and-genetic-characteristics-and-long-term-follow-up-of-five-patients-with-malonyl-coa-decarboxylase-deficiency
#5
JOURNAL ARTICLE
J M Zhang, L L Hao, W J Qiu, H W Zhang, T Chen, W J Ji, Y Zhang, F Liu, X F Gu, S H Yang, L S Han
BACKGROUND: Malonyl-CoA decarboxylase (MLYCD) deficiency, also known as malonic aciduria (MAD), is a rare autosomal recessive inherited metabolic defect. In this study, we aimed to investigate the clinical and molecular features of five patients with MAD in order to increase clinicians' awareness of the disease. METHODS: Sanger sequencing was used to detect and genetically analyze the MLYCD variations in the preexisting patients and their parents. RESULTS: Five patients with MAD (5 months to 9...
July 27, 2024: Brain & Development
https://read.qxmd.com/read/39068045/effect-of-cannabidiol-as-a-neuroprotective-agent-on-neurodevelopmental-impairment-in-rats-with-neonatal-hypoxia
#6
JOURNAL ARTICLE
Ángela Hernández-Suárez, Luis A Marin-Castañeda, Carmen Rubio, Héctor Romo-Parra
OBJECTIVE: This study aims to investigate the neuroprotective effects of cannabidiol (CBD) on neurodevelopmental impairments in rats subjected to neonatal hypoxia, specifically examining its potential to mitigate motor and sensory deficits without the confounding effects of ischemia. METHODS: Neonatal Sprague-Dawley rats were allocated to one of four groups: Control, Control-CBD, Hypoxia, and Hypoxia-CBD. Hypoxia was induced on postnatal days 0 and 1. CBD (50 mg/kg) was administered orally for 14 days starting at postnatal day 0...
July 26, 2024: Brain & Development
https://read.qxmd.com/read/38972777/glass-syndrome-derived-from-chromosomal-breakage-downstream-region-of-satb2
#7
JOURNAL ARTICLE
Keiko Shimojima Yamamoto, Rina Shimomura, Hiromichi Shoji, Toshiyuki Yamamoto
BACKGROUND: Glass syndrome, derived from chromosomal 2q33.1 microdeletions, manifests with intellectual disability, microcephaly, epilepsy, and distinctive features, including micrognathia, down-slanting palpebral fissures, cleft palate, and crowded teeth. Recently, SATB2 located within the deletion region, was identified as the causative gene responsible for Glass syndrome. Numerous disease-causing variants within the SATB2 coding region have been reported. OBJECTIVE: Given the presentation of intellectual disability and multiple congenital anomalies in a patient with a de novo reciprocal translocation between chromosomes 1 and 2, disruption of the causative gene(s) was suspected...
July 6, 2024: Brain & Development
https://read.qxmd.com/read/38942709/epidemiological-study-on-pediatric-onset-dystonia-in-japan-a-questionnaire-based-survey
#8
JOURNAL ARTICLE
Yuta Suenaga, Eri Takeshita, Kaoru Yamamoto, Noriko Sumitomo, Shimpei Baba, Yuko Shimizu-Motohashi, Takashi Saito, Hirofumi Komaki, Eiji Nakagawa, Masayuki Sasaki
OBJECTIVE: This study aimed to investigate the clinical characteristics of pediatric-onset dystonia in Japan, addressing the diagnostic challenges arising from symptom variations and etiological diversity. METHODS: From 2020 to 2022, questionnaires were distributed to 1218 board certified child neurologists (BCCNs) by Japanese Society of Child Neurology. In the primary survey, participants were asked to report the number of patients with pediatric-onset dystonia under their care...
June 27, 2024: Brain & Development
https://read.qxmd.com/read/38876823/serum-25-oh-d-and-vitamin-k-1-levels-in-patients-with-severe-motor-and-intellectual-disability-a-japanese-single-center-experience
#9
JOURNAL ARTICLE
Tomoko Sakai, Tsutomu Oishi, Yusuke Takashina, Masanobu Hirao
PURPOSE: To investigate whether patients with severe motor and intellectual disability (SMID) have nutritional vitamin D and K insufficiencies and clarify the required vitamin supplementation. METHODS: This prospective observational study enrolled Japanese adults with SMID receiving institutionalized care who underwent blood sampling between February 2020 and February 2022 during annual medical checkups. Serum vitamin K1 and 25-hydroxy vitamin D (25(OH)D) levels were measured to determine their relationship with serum uncarboxylated osteocalcin (ucOC) levels...
June 13, 2024: Brain & Development
https://read.qxmd.com/read/38556384/effects-of-increased-physical-therapy-staffing-in-the-neonatal-intensive-care-unit-on-oral-feeding-maturation-and-neurodevelopment-of-extremely-low-birth-weight-infants
#10
JOURNAL ARTICLE
Yoshinori Morioka, Masayuki Nonogaki, Daiyu Kobayashi, Junji Nishimoto, Shigeru Obayashi
BACKGROUND: It remains a matter of debate as to what extent early intervention may facilitate long-term functional outcomes of preterm infants in the neonatal intensive care unit (NICU). We aimed to examine the effect of increasing physical therapy (PT) staff dedicated to the NICU on temporal changes (initiation, duration) of PT interventions and functional outcomes (acquisition of full oral feeding and Hammersmith Neonatal Neurological Examination). METHODS: Extremely low birth weight infants, retrospectively collected from an academic medical center, were allocated to two subgroups, either a baseline period (N = 48) without NICU-dedicated PT staff (non-dedicated group) or a quality improvement period (N = 42) with additional dedicated staff (dedicated group)...
June 2024: Brain & Development
https://read.qxmd.com/read/38493042/metabolic-etiologies-in-children-with-infantile-epileptic-spasm-syndrome-experience-at-a-tertiary-pediatric-neurology-center
#11
JOURNAL ARTICLE
Merve Feyza Yüksel, Neslihan Doğulu, Miraç Yıldırım, Engin Köse, Ömer Bektaş, Fatma Tuba Eminoğlu, Serap Teber
OBJECTIVE: Infantile epileptic spasm syndrome (IESS), including West syndrome (WS) and infantile spasm (IS), causes a challenging prognosis, particularly when associated with metabolic etiologies. METHODS: This study, conducted at a tertiary pediatric neurology center, explored the prevalence and clinical features of inborn errors of metabolism in 112 children with IESS over 10 years. RESULTS: Most patients presented with seizures, primarily flexor spasms, and the median age at onset was 5 months...
June 2024: Brain & Development
https://read.qxmd.com/read/38782623/glucose-instability-and-outcomes-of-neonates-with-hypoxic-ischemic-encephalopathy-undergoing-therapeutic-hypothermia
#12
JOURNAL ARTICLE
Mahmoud A M Ali, Mohsen A A Farghaly, Injy El-Dib, Sreenivas Karnati, Hany Aly, Ceyda Acun
BACKGROUND: To investigate the prevalence and associated outcomes of glucose abnormalities in infants with hypoxic ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH). METHODS: Glucose values were reviewed in all HIE infants. Pearson's correlation was used to assess the association of hypo- and hyperglycemic episodes with neonatal brain MRI and neurodevelopmental outcomes (NDO) at 12 & 24 months. RESULTS: Of 153 infants included, 31, 56 and 43 had episodes of hypo-, hyperglycemia and combined, respectively...
May 22, 2024: Brain & Development
https://read.qxmd.com/read/38740533/variation-in-neuroimaging-and-outcomes-in-patients-with-sturge-weber-syndrome-type-iii
#13
JOURNAL ARTICLE
Hadjinicolaou Aristides, Quinlan Aisling, Liu Shanshan, Zhang Bo, Takeoka Masanori, Sahin Mustafa, Prabhu Sanjay P, Pinto Anna Lecticia
OBJECTIVES: Sturge Weber syndrome (SWS) is a neurovascular condition with an estimated incidence of 1 in 20,000 to 50,000 live births. SWS Types I and II involve cutaneous and ophthalmological findings, with neurological involvement in Type I. SWS Type III is exclusive to brain stigmata. Our study aims to describe the characteristics of brain MRI findings and report neuroradiological features with seizure and cognitive outcomes in patients with SWS Type III. METHODS: This is a retrospective case series examining the clinical, radiological, and cognitive characteristics of patients with SWS Type III referred to the SWS Clinic at Boston Children's Hospital...
May 12, 2024: Brain & Development
https://read.qxmd.com/read/38705801/intrauterine-twin-environment-and-genetic-factors-subliminally-affecting-general-movements-in-preterm-infants
#14
JOURNAL ARTICLE
Eriko Eto, Tomoki Maeda, Osamu Kobayashi, Kenji Ihara
BACKGROUND: Understanding background factors is beneficial for interpreting general movements (GMs). This study examines the factors involved in preterm-writhing GMs by comparing twins and singletons. METHOD: The subjects were 107 infants cared for at Oita University. The cohort consisted of very-low-birth-weight infants, including twins with a birth weight < 2000 g. The median gestational age (GA) was 29 weeks 1 day. The subjects consisted of 75 singletons, 32 twins (16 pairs), 20 monochorionic twins (M-twins), and 12 dichorionic twins (D-twins)...
May 4, 2024: Brain & Development
https://read.qxmd.com/read/38641466/adolescent-onset-epilepsy-and-deterioration-associated-with-cad-deficiency-a-case-report
#15
Sebastián Silva, Mónica Rosas, Benjamín Guerra, Marión Muñoz, Atsushi Fujita, Masamune Sakamoto, Naomichi Matsumoto
INTRODUCTION: CAD (MIM*114010) encodes a large multifunctional protein with the enzymatic activity of the first three enzymes initiating and controlling the de novo pyrimidine biosynthesis pathway. Biallelic pathogenic variants in CAD cause the autosomal recessive developmental and epileptic encephalopathy 50 (MIM #616457) or CAD deficiency presenting with epilepsy, status epilepticus (SE), neurological deterioration and anemia with anisopoikilocytosis. Mortality is around 9% of patients, mainly related to the no use of its specific treatment with uridine...
April 18, 2024: Brain & Development
https://read.qxmd.com/read/38302343/key-considerations-for-the-diagnosis-of-guillain-barr%C3%A3-syndrome-in-pediatric-populations
#16
LETTER
Tejas C Sekhar
No abstract text is available yet for this article.
April 2024: Brain & Development
https://read.qxmd.com/read/38556383/developmental-changes-in-prefrontal-cortex-activation-in-children-with-or-without-autism-spectrum-traits-on-near-infrared-spectroscopy
#17
JOURNAL ARTICLE
Taemi Niimi, Yuji Inaba, Hideo Honda
BACKGROUND: Autism spectrum disorder (ASD) ranges from mild to severe symptoms, with autistic traits possibly distributed throughout the population. However, the precise neurodevelopmental differences in children with autistic traits remain unknown. SUBJECTS AND METHODS: Fifty-three healthy volunteers (32 male and 21 female, mean [standard deviation] age: 12.9 [2.5] years) having a normal intelligence quotient and without social impairment were divided into two groups according to scores of the Pervasive Developmental Disorders Autism Society Japan Rating Scale (PARS)...
March 30, 2024: Brain & Development
https://read.qxmd.com/read/38519270/prophylactic-antiseizure-medications-for-recurrent-status-epilepticus-in-nonsyndromic-childhood-epilepsy
#18
JOURNAL ARTICLE
Hirokazu Takeuchi, Norimichi Higurashi, Yurika Toga
PURPOSE: The management of status epilepticus (SE) has mainly focused on the termination of ongoing SE episodes. However, long-term therapeutic strategies for the prevention of SE are lacking. This study aimed to investigate the effectiveness of prophylactic antiseizure medications (ASMs) for SEs in nonsyndromic childhood epilepsy. METHODS: This retrospective study was conducted at Jikei University Hospital. Patients <18 years of age, diagnosed with epilepsy, and experiencing three or more SE episodes within 1 year between April 1, 2017, and October 1, 2021, were included...
March 21, 2024: Brain & Development
https://read.qxmd.com/read/38480026/a-female-case-of-l1-syndrome-that-may-have-developed-due-to-skewed%C3%A2-x%C3%A2-inactivation
#19
Tatsuo Mori, Mutsuki Nakano, Takahiro Tayama, Aya Goji, Yoshihiro Toda, Shinichi Kameyama, Takeshi Mizuguchi, Maki Urushihara, Naomichi Matsumoto
BACKGROUND: Heterozygous L1CAM variants cause L1 syndrome with hydrocephalus and aplasia/hypoplasia of the corpus callosum. L1 syndrome usually has an X-linked recessive inheritance pattern; however, we report a rare case occurring in a female child. CASE PRESENTATION: The patient's family history was unremarkable. Fetal ultrasonography revealed enlarged bilateral ventricles of the brain and hypoplasia of the corpus callosum. The patient was born at 38 weeks and 4 days of gestation...
March 12, 2024: Brain & Development
https://read.qxmd.com/read/38448301/long-term-efficacy-of-intrathecal-cyclodextrin-in-patients-with-niemann-pick-disease-type-c
#20
JOURNAL ARTICLE
Muneaki Matsuo, Takafumi Sakakibara, Yoshio Sakiyama, Tetsumin So, Motomichi Kosuga, Toshihiko Kakiuchi, Fumio Ichinose, Takuji Nakamura, Yoichi Ishitsuka, Tetsumi Irie
BACKGROUND AND OBJECTIVES: Niemann-Pick type C (NPC) is a rare lysosomal storage disease characterized by hepatosplenomegaly and progressive neurological deterioration due to abnormal intracellular cholesterol transport. Cyclic oligosaccharide 2-hydroxypropyl-β-cyclodextrin (HPBCD) is an effective treatment for NPC; however, few reports have shown its long-term efficacy and safety. To demonstrate long-term efficacy and safety of intrathecal HPBCD (IT-HPBCD) treatment for NPC, we herein reports five patients with NPC treated using IT-HPBCD for 4-11 years...
March 5, 2024: Brain & Development
journal
journal
27751
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.